Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,629 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07665684 | Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer(SONIC) | not yet recruiting | Phase 1 / Phase 2 | 67 | University Health Network, TorontoOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07663006 | Breast and Cervical Cancer Stigma in Rwanda | not yet recruiting | N/A | 1,116 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 23, 2026 |
| clinicaltrials |
| NCT07663513 | Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Chemotherapy as Neoadjuvant Therapy for Advanced Ovarian Cancer | not yet recruiting | Phase 2 | 36 | Fudan UniversityOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07657416 | NK521 in the Treatment of Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 18 | Base Therapeutics (Shanghai) Co., Ltd.INDUSTRY | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07339384 | Signatera Assessment in Early-Stage Endometrial Cancer(SIGNAL-EMC 101) | not yet recruiting | N/A | 1,010 | Natera, Inc.INDUSTRY | 1 | Jun 17, 2026 | clinicaltrials |
| NCT07644910 | Nudging Preventive Screening Via Message Framing and Bundling | not yet recruiting | N/A | 235,000 | University of ChileOTHER | 0 | Jun 17, 2026 | clinicaltrials |
| NCT07652515 | A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer | not yet recruiting | Phase 4 | 100 | GlaxoSmithKlineINDUSTRY | 0 | Jun 17, 2026 | clinicaltrials |
| NCT07649174 | Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial | not yet recruiting | Phase 2 | 134 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07647653 | Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian Cancer | not yet recruiting | Phase 2 | 120 | Shandong UniversityOTHER | 0 | Jun 15, 2026 | clinicaltrials |
| NCT07642531 | A Modular Cloud Platform For Fertility Preservation | not yet recruiting | N/A | 140 | Biruni UniversityOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07645716 | Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic Oncology(GOLD) | not yet recruiting | — | 400 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07462663 | SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer(SHAPE-ENDO) | not yet recruiting | Phase 4 | 80 | Hospital Universitari de BellvitgeOTHER | 0 | Jun 10, 2026 | clinicaltrials |
| NCT07639801 | 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors | not yet recruiting | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 0 | Jun 10, 2026 | clinicaltrials |
| NCT07634601 | Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer | not yet recruiting | Phase 2 | 50 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07623642 | A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. | not yet recruiting | Phase 2 | 227 | GV20 TherapeuticsINDUSTRY | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07631871 | An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy | not yet recruiting | Phase 2 | 10 | Haihua YuanOTHER | 0 | Jun 8, 2026 | clinicaltrials |
| NCT07631884 | Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor | not yet recruiting | Phase 2 | 15 | Haihua YuanOTHER | 0 | Jun 8, 2026 | clinicaltrials |
| NCT07634094 | Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer | not yet recruiting | Phase 2 | 28 | Kalinski, Pawel, MD, PhDOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07627620 | Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer | not yet recruiting | Phase 2 | 54 | Hunan Cancer HospitalOTHER | 0 | Jun 4, 2026 | clinicaltrials |
| NCT07600515 | Evaluation of Persistent Infection by Oncogenic Human Papillomavirus (HPV) in Patients Treated for Cervical Carcinoma and Its Relation to Prognostic Factors(ANIHTA) | not yet recruiting | — | 100 | Instituto do Cancer do Estado de São PauloOTHER | 0 | Jun 3, 2026 | clinicaltrials |
| NCT07617818 | QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer | not yet recruiting | Phase 2 | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Jun 1, 2026 | clinicaltrials |
| NCT07214506 | Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity(HOPE) | not yet recruiting | N/A | 100 | University of ArizonaOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07613567 | A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer | not yet recruiting | Phase 3 | 486 | Fujian Cancer HospitalOTHER_GOV | 1 | May 29, 2026 | clinicaltrials |
| NCT07608445 | Physiatry-Led Cancer Prehabilitation During Neoadjuvant Systemic Therapy to Improve Function in Stage III-IVA Gynecologic Cancer Patients | not yet recruiting | N/A | 25 | City of Hope Medical CenterOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT07609082 | Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Ovarian Cancer Surgery(ADAPT-OC) | not yet recruiting | N/A | 36 | Jordan LeitchOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT07606677 | Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women | not yet recruiting | — | 1,465 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | May 26, 2026 | clinicaltrials |
| NCT07605247 | Tirzepatide in the Treatment of Endometrial Cancer(TREAT-EC) | not yet recruiting | Phase 2 | 30 | Rutgers, The State University of New JerseyOTHER | 0 | May 22, 2026 | clinicaltrials |
| NCT07583329 | Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy(V-COSMOS) | not yet recruiting | — | 160 | Cukurova UniversityOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT07591623 | OCRA Distress & Unmet Needs | not yet recruiting | N/A | 250 | M.D. Anderson Cancer CenterOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07591831 | Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer | not yet recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07593066 | PRIORITY Study in Cervical Cancer(PRIORITY) | not yet recruiting | — | 700 | Pontificia Universidad Catolica de ChileOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07593339 | Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery | not yet recruiting | N/A | 30 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 0 | May 18, 2026 | clinicaltrials |
| NCT07593833 | Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection | not yet recruiting | — | 1,000 | Tongji HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07586449 | A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian Cancer(RESO) | not yet recruiting | — | 500 | Zhejiang Cancer HospitalOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07580651 | Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring((CurieInVivo)) | not yet recruiting | N/A | 20 | CISSS de Chaudière-AppalachesOTHER_GOV | 0 | May 12, 2026 | clinicaltrials |
| NCT07581288 | Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression(MIRA) | not yet recruiting | — | 50 | University of British ColumbiaOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT07576842 | Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV | not yet recruiting | N/A | 750 | University of California, San DiegoOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07555600 | Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors(E-FACTOR) | not yet recruiting | N/A | 300 | Centre Leon BerardOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT07541859 | Breast and Cervical Cancer Awareness Training in Visually Impaired Women(GORSEM) | not yet recruiting | N/A | 74 | Marmara UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07542704 | A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies | not yet recruiting | Phase 1 | 48 | Kumquat Biosciences Inc.INDUSTRY | 0 | Apr 21, 2026 | clinicaltrials |
| NCT07532148 | Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | not yet recruiting | Phase 1 | 24 | Chong Kun Dang PharmaceuticalINDUSTRY | 0 | Apr 15, 2026 | clinicaltrials |
| NCT07522697 | Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4(MITO END-4) | not yet recruiting | Phase 2 | 48 | National Cancer Institute, NaplesOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07523152 | Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study(SAPPHIRE) | not yet recruiting | N/A | 42 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07189702 | Plant-Based Nutrition for Breast or Endometrial Cancer(BEND-MBEC) | not yet recruiting | N/A | 60 | University of RochesterOTHER | 0 | Apr 8, 2026 | clinicaltrials |
| NCT07514325 | MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer(MASTEC) | not yet recruiting | N/A | 61 | Radboud University Medical CenterOTHER | 0 | Apr 7, 2026 | clinicaltrials |
| NCT07516210 | Adaptive Radiotherapy for Safe Hypofractionation(ART-Hypo) | not yet recruiting | Phase 2 | 264 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07512973 | Single-channel Fibroid Morcellation System Used in Clinical Research on Laparoscopic Myomectomy | not yet recruiting | N/A | 78 | First People's Hospital of HangzhouOTHER | 0 | Apr 6, 2026 | clinicaltrials |
| NCT07501676 | Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief(TUNES) | not yet recruiting | N/A | 60 | Weill Medical College of Cornell UniversityOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07497074 | JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer | not yet recruiting | Phase 2 | 78 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07497802 | Mindfulness-Based Psychoeducation for Women With Gynecological Cancer(MIND-GYN) | not yet recruiting | N/A | 96 | Ondokuz Mayıs UniversityOTHER | 1 | Mar 27, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 24, 2026source: clinicaltrials